StockNews.com Initiates Coverage on bluebird bio (NASDAQ:BLUE)
Investment analysts at StockNews.com started coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a report released on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock. A number of other analysts have also weighed in on BLUE. Barclays cut their price objective on shares of bluebird bio from […]
Investment analysts at StockNews.com started coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a report released on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock. A number of other analysts have also weighed in on BLUE. Barclays cut their price objective on shares of bluebird bio from […]
-logo-1200x675.jpg&w=240&h=240&zc=2){kind=logo}